Ventyx Biosciences, Inc. (VTYX)
9.09
+0.34
(+3.89%)
USD |
NASDAQ |
Dec 31, 12:48
Ventyx Biosciences EPS Diluted (Quarterly): -0.3202 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -0.8083 |
| Genprex, Inc. | -4.996 |
| Moderna, Inc. | -0.5128 |
| Neumora Therapeutics, Inc. | -0.3507 |
| BioAge Labs, Inc. | -0.5626 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.83M |
| Total Expenses (Quarterly) | 22.83M |
| Enterprise Value | 441.77M |
| Earnings Yield | -16.50% |
| Normalized Earnings Yield | -16.46 |